Megestrol acetate in cachexia and anorexia

Shing shing Yeh; Michael W. Schuster

doi:10.2147/nano.2006.1.4.411

Megestrol acetate in cachexia and anorexia

Shing shing Yeh
, Michael W. Schuster

Medical Oncology

VA Medical Center

Research output: Contribution to journal › Review article › peer-review

42 Scopus citations

Abstract

The aim is to review major clinical trials that have used megestrol acetate (MA) in the treatment of cachexia across several disease states. A review of general usage and potential side-effects are discussed. A theory that the newly approved nanocrystal formation of MA can better deliver this potent medication for treatment will also be reviewed.

Original language	English
Pages (from-to)	411-416
Number of pages	6
Journal	International journal of nanomedicine
Volume	1
Issue number	4
DOIs	https://doi.org/10.2147/nano.2006.1.4.411
State	Published - 2006

Keywords

Cachexia
Megestrol acetate
Nanocrystalline particles

Access to Document

10.2147/nano.2006.1.4.411

Cite this

@article{2b0e5532550744949398d34c869330a2,

title = "Megestrol acetate in cachexia and anorexia",

abstract = "The aim is to review major clinical trials that have used megestrol acetate (MA) in the treatment of cachexia across several disease states. A review of general usage and potential side-effects are discussed. A theory that the newly approved nanocrystal formation of MA can better deliver this potent medication for treatment will also be reviewed.",

keywords = "Cachexia, Megestrol acetate, Nanocrystalline particles",

author = "Yeh, \{Shing shing\} and Schuster, \{Michael W.\}",

year = "2006",

doi = "10.2147/nano.2006.1.4.411",

language = "English",

volume = "1",

pages = "411--416",

journal = "International journal of nanomedicine",

issn = "1178-2013",

number = "4",

}

TY - JOUR

T1 - Megestrol acetate in cachexia and anorexia

AU - Yeh, Shing shing

AU - Schuster, Michael W.

PY - 2006

Y1 - 2006

N2 - The aim is to review major clinical trials that have used megestrol acetate (MA) in the treatment of cachexia across several disease states. A review of general usage and potential side-effects are discussed. A theory that the newly approved nanocrystal formation of MA can better deliver this potent medication for treatment will also be reviewed.

AB - The aim is to review major clinical trials that have used megestrol acetate (MA) in the treatment of cachexia across several disease states. A review of general usage and potential side-effects are discussed. A theory that the newly approved nanocrystal formation of MA can better deliver this potent medication for treatment will also be reviewed.

KW - Cachexia

KW - Megestrol acetate

KW - Nanocrystalline particles

UR - https://www.scopus.com/pages/publications/34548654454

U2 - 10.2147/nano.2006.1.4.411

DO - 10.2147/nano.2006.1.4.411

M3 - Review article

C2 - 17722275

AN - SCOPUS:34548654454

SN - 1178-2013

VL - 1

SP - 411

EP - 416

JO - International journal of nanomedicine

JF - International journal of nanomedicine

IS - 4

ER -

Megestrol acetate in cachexia and anorexia

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this